SwePub
Sök i SwePub databas

  Extended search

Träfflista för sökning "WFRF:(Skalkidou Alkistis 1977 ) "

Search: WFRF:(Skalkidou Alkistis 1977 )

  • Result 61-70 of 163
Sort/group result
   
EnumerationReferenceCoverFind
61.
  • Fransson, Emma, PhD, 1973-, et al. (author)
  • Maternal perinatal depressive symptoms trajectories and impact on toddler behavior : the importance of symptom duration and maternal bonding
  • 2020
  • In: Journal of Affective Disorders. - : Elsevier BV. - 0165-0327 .- 1573-2517. ; 273, s. 542-551
  • Journal article (peer-reviewed)abstract
    • BACKGROUND: Maternal perinatal depression is a public health problem affecting mothers and children worldwide. This study aimed to increase the knowledge regarding the impact of timing of maternal depression on child behavioral difficulties at 18 months, taking into consideration child gender and maternal bonding.METHODS: Data from a Swedish population-based longitudinal mother-infant study (n = 1,093) were used for linear regression modeling. Associations between antenatal depression, postpartum depression, persistent depression and child behavioral problems were assessed.RESULTS: Maternal antenatal and persistent depression were associated with higher Child Behavior Checklist scores. Girls were affected to a greater degree. Postpartum bonding mediated most of the negative effects of postpartum and persistent depression on child behavior; not the effects of antenatal depression, however.LIMITATIONS: Child behavioral problems were reported by the mother. Information regarding paternal depressive symptoms was lacking.CONCLUSION: Different onset and timing of maternal depression showed distinct associations with child behavioral problems. The effects of antenatal depression were not mediated by maternal bonding, indicating underlying mechanisms possibly related to fetal programming. Screening of depressive symptoms even during pregnancy would be important in routine care in order to early identify and treat depression.
  •  
62.
  • Gambadauro, Pietro, et al. (author)
  • Conception by means of in vitro fertilization is not associated with maternal depressive symptoms during pregnancy or postpartum
  • 2017
  • In: Fertility and Sterility. - : ELSEVIER SCIENCE INC. - 0015-0282 .- 1556-5653. ; 108:2, s. 325-332
  • Journal article (peer-reviewed)abstract
    • Objective: To study whether conception by means of in vitro fertilization (IVF) is associated with maternal depressive symptoms during pregnancy or postpartum.Design: Longitudinal observational study. Setting: University hospital.Patient(s): A total of 3,283 women with singleton pregnancies receiving antenatal care and delivering in Uppsala from 2010 to 2015.Intervention(s): A web-based self-administered structured questionnaire including sociodemographic, clinical and pregnancy-related items, and the Edinburgh Postnatal Depression Scale (EPDS) was delivered at 17 and 32 gestational weeks and at 6 weeks and 6 months postpartum.Main Outcome Measure(s): Prevalence of significant depressive symptoms (EPDS >= 12) and EPDS scores.Result(s): A total of 167 women (5%) had conceived via IVF and 3,116 (95%) had a spontaneous pregnancy. IVF mothers were more frequently >= 35 years of age (46.1% vs. 22.6%) and primiparous (71.7% vs. 49.9%) and had a higher cesarean delivery rate (22.4% vs. 14.2%). Demographic and clinical characteristics were otherwise similar between the two groups. Significant depressive symptoms were reported by 12.8%, 12.4%, 13.8%, and 11.9% of women at 17 and 32 gestational weeks and 6 weeks and 6 months postpartum, respectively. The prevalence of depressive symptoms and the EPDS scores during pregnancy and postpartum were similar between women conceiving spontaneously or through IVF. The mode of conception was not associated with significant depressive symptoms at any time point, even when adjusting for several possible confounders in multivariable logistic regression analysis.Conclusion(s): Despite the psychologic distress characterizing subfertility and its treatment, conception by means of IVF is not associated with maternal depressive symptoms during pregnancy or postpartum.
  •  
63.
  •  
64.
  • Georgakis, Marios K., et al. (author)
  • Surgical menopause in association with cognitive function and risk of dementia : A systematic review and meta-analysis
  • 2019
  • In: Psychoneuroendocrinology. - : PERGAMON-ELSEVIER SCIENCE LTD. - 0306-4530 .- 1873-3360. ; 106, s. 9-19
  • Research review (peer-reviewed)abstract
    • Introduction: Experimental and epidemiological studies suggest female sex hormones to have long-lasting neuroprotective and anti-ageing properties. Surgically-induced menopause leads to a premature cessation of exposure to female sex hormones and could thus impact late-life cognitive function. Yet, evidence remains controversial. Methods: We systematically reviewed literature for articles investigating the association of surgical menopause (defined as bilateral oophorectomy before the onset of menopause) with risk of dementia, cognitive performance, cognitive decline, and Alzheimer's disease neuropathological indices later in life. We evaluated study quality with the Newcastle-Ottawa scale and performed random-effects meta-analyses. Results: We identified 11 eligible studies (N = 18,867). Although surgical menopause at any age was not associated with risk of dementia (4 studies; HR: 1.16, 95%CI: 0.96-1.43), early surgical menopause (<= 45 years of age) was associated with a statistically significantly higher risk (2 studies; HR: 1.70, 95%CI: 1.07-2.69). Surgical menopause at any age was associated with faster decline in verbal memory, semantic memory, and processing speed, whereas early surgical menopause was further associated with faster global cognitive decline. No heterogeneity was noted. Among women undergoing surgical menopause, a younger age at surgery was associated with faster decline in global cognition, semantic and episodic memory, worse performance in verbal fluency and executive function, and accumulation of Alzheimer's neuropathology. Conclusions: Current evidence is limited, but suggests surgical menopause induced by bilateral oophorectomy at <= 45 years of age to be associated with higher risk of dementia and cognitive decline. Additional large-scale cohort studies are necessary to replicate these findings.
  •  
65.
  • Geusens, Femke, et al. (author)
  • ‘I had to Educate Myself’ : A thematic analysis of online stillbirth stories to improve obstetric care
  • 2024
  • In: British Journal of Obstetrics and Gynecology. - : John Wiley & Sons. - 1470-0328 .- 1471-0528. ; 131:8, s. 1120-1128
  • Journal article (peer-reviewed)abstract
    • Objective: To examine which met and unmet needs are discussed in stillbirth stories shared on YouTube with the aim to improve obstetric care.Design: Inductive thematic analysis of 19 English-language stillbirth stories uploaded to YouTube.Setting: Online setting, YouTube video content.Sample: Women who experienced stillbirth and shared a video on YouTube talking about their experience.Methods: We conducted a thorough textual reading of the transcripts following Braun and Clarke's guidelines for thematic analysis.Main outcome measures: Codes were developed and grouped into themes.Results: Although some women actively used their birth videos to call out shortcomings in their care, most others used their platform for other purposes such as destigmatisation, awareness and support, and rather unintentionally provided insight into their met and unmet needs. When analysing their birth stories, three major themes emerged: choice and decision-making, education and information, and behaviour of healthcare providers.Conclusions: This study demonstrates the value of birth stories in research. We identified three major opportunities for improvement of obstetric care: being provided with options and being able to make choices in the decision-making process are clearly valued, but there are some caveats: women and other childbearing individuals need timely and continuous information, and more attention is needed for emotional intelligence training of healthcare providers.
  •  
66.
  • Gidén, Karin, et al. (author)
  • Feeling better? - Identification, interventions, and remission among women with early postpartum depressive symptoms in Sweden : a nested cohort study
  • 2024
  • In: European psychiatry. - : Cambridge University Press. - 0924-9338 .- 1778-3585. ; 67:1
  • Journal article (peer-reviewed)abstract
    • BackgroundPostpartum depression affects around 12% of mothers in developed countries, with consequences for the whole family. Many women with depressive symptoms remain undetected and untreated. The aim of this study was to investigate to what extent women with depressive symptoms at 6 weeks postpartum are identified by the healthcare system, the interventions they received, and remission rates at 6 months postpartum.MethodsPostpartum women scoring 12–30 on the Edinburgh Postnatal Depression Scale (EPDS) at 6 weeks after delivery (n = 697) were identified from the longitudinal cohort study “Biology, Affect, Stress, Imaging and Cognition” (BASIC) in Uppsala, Sweden. A total of 593 women were included. Background and remission information at 6 months was collected from the BASIC dataset. Medical records were examined to identify interventions received.ResultsMost women (n = 349, 58.7%) were not identified by the healthcare system as having depressive symptoms and 89% lacked any record of interventions. Remission rates at 6 months postpartum were 69% in this group. Among women identified by the healthcare system, 90% received interventions and about 50% were in remission at 6 months postpartum. The EPDS reduction during the study period was largest in the group identified by the child health services (CHS, −5.15) compared to the non-identified (−4.24, p < 0.001).ConclusionsDespite screening guidelines, many women with depressive symptoms had no documentation of screening or interventions by the healthcare system. Furthermore, a significant proportion did not achieve remission despite interventions. Being identified by CHS was associated with the largest reduction of symptoms. Research is needed to understand gaps in the healthcare processes, to better identify peripartum depression.
  •  
67.
  • Guintivano, Jerry, et al. (author)
  • Meta-Analyses of Genome-Wide Association Studies for Postpartum Depression
  • 2023
  • In: American Journal of Psychiatry. - : American Psychiatric Association Publishing. - 0002-953X .- 1535-7228. ; 180:12, s. 884-895
  • Journal article (peer-reviewed)abstract
    • OBJECTIVE: Postpartum depression (PPD) is a common subtype of major depressive disorder (MDD) that is more heritable, yet is understudied in psychiatric genetics. The authors conducted meta-analyses of genome-wide association studies (GWASs) to investigate the genetic architecture of PPD.METHOD: Meta-analyses were conducted on 18 cohorts of European ancestry (17,339 PPD cases and 53,426 controls), one cohort of East Asian ancestry (975 cases and 3,780 controls), and one cohort of African ancestry (456 cases and 1,255 controls), totaling 18,770 PPD cases and 58,461 controls. Post-GWAS analyses included 1) single-nucleotide polymorphism (SNP)-based heritability ([Formula: see text]), 2) genetic correlations between PPD and other phenotypes, and 3) enrichment of the PPD GWAS findings in 27 human tissues and 265 cell types from the mouse central and peripheral nervous system.RESULTS: No SNP achieved genome-wide significance in the European or the trans-ancestry meta-analyses. The [Formula: see text] of PPD was 0.14 (SE=0.02). Significant genetic correlations were estimated for PPD with MDD, bipolar disorder, anxiety disorders, posttraumatic stress disorder, insomnia, age at menarche, and polycystic ovary syndrome. Cell-type enrichment analyses implicate inhibitory neurons in the thalamus and cholinergic neurons within septal nuclei of the hypothalamus, a pattern that differs from MDD.CONCLUSIONS: While more samples are needed to reach genome-wide levels of significance, the results presented confirm PPD as a polygenic and heritable phenotype. There is also evidence that despite a high correlation with MDD, PPD may have unique genetic components. Cell enrichment results suggest GABAergic neurons, which converge on a common mechanism with the only medication approved by the U.S. Food and Drug Administration for PPD (brexanolone).
  •  
68.
  • Hellgren, Charlotte, 1985-, et al. (author)
  • Allopregnanolone levels and depressive symptoms during pregnancy in relation to single nucleotide polymorphisms in the allopregnanolone synthesis pathway
  • 2017
  • In: Hormones and Behavior. - : Elsevier. - 0018-506X .- 1095-6867. ; 94, s. 106-113
  • Journal article (peer-reviewed)abstract
    • Allopregnanolone, a neurosteroid whose levels rise throughout gestation, putatively stabilizes antenatal mood. The present study aimed to investigate associations of plasma allopregnanolone to antenatal depressive symptoms, as well as to genetic and obstetric factors. Allopregnanolone plasma levels from 284 pregnant women were measured around gestational week 18. Haplotype tag single nucleotide polymorphisms in the aldo-keto reductase family 1, members C2 and C4 (AKR1C2, AKR1C4), and steroid 5 alpha-reductase 1 and 2 (SRD5A1, and SRD5A2) genes were genotyped in a larger sample of pregnant women (n=1351). The Edinburgh Postnatal Depression Scale (EPDS) was administered via web-questionnaires in gestational weeks 17 and 32. Demographic and obstetric data was retrieved from web-questionnaires and medical records. There was no association between allopregnanolone levels and depressive symptoms. Furthermore, no associations between allopregnanolone level and synthesis pathway genotypes were found after accounting for multiple comparisons. However, exploratory analyses suggested that the women who were homozygous for the minor allele of the AKR1C2 polymorphism rs1937863 had nominally lower allopregnanolone levels and lower depression scores in gestational week 17, but also the highest increase in depression scores between week 17 and 32. Additionally, higher body mass index was associated with lower allopregnanolone levels. The results do not support second trimester plasma allopregnanolone as a mood stabilizing factor. However, we speculate that AKR1C2 variation may alter the susceptibility to depressive symptoms through effects on central allopregnanolone synthesis. Another implication of this study is that the relationship between neuroactive steroids and obesity in pregnancy deserves to be investigated.
  •  
69.
  • Hellgren, Charlotte, 1985-, et al. (author)
  • Cortisol awakening response in late pregnancy in women with previous or ongoing depression
  • 2013
  • In: Psychoneuroendocrinology. - : Elsevier BV. - 0306-4530 .- 1873-3360. ; 38:12, s. 3150-3154
  • Journal article (peer-reviewed)abstract
    • Pregnancy is associated with increased basal cortisol levels, and decreased hypothalamic-pituitary-adrenal (HPA) axis reactivity. The cortisol awakening response (CAR) is a measure of HPA-axis reactivity which has been reported to be increased in patients with ongoing depressive disorder and in individuals with remitted depression. In this study, we investigated HPA-axis reactivity in pregnant women with ongoing or previous depression. The CAR was assessed by measurement of salivary cortisol at awakening and 15, 30, and 45min post-awakening. Based on structured psychiatric interviews and repeated measurements of depressive symptoms during pregnancy, 134 women were included in one of the three groups: never depressed (n=57), depressed prior to the current pregnancy (n=39), and depressed during the current pregnancy (n=38). Given the prior findings of increased CAR in non-pregnant depressed subjects, we hypothesized that an ongoing or previous depression would result in a higher CAR. Contrary to our hypothesis, a mixed models analysis failed to yield significant group differences. Thus, our results suggest that never depressed pregnant women and women with depression during pregnancy have similar cortisol awakening responses. Furthermore, our findings suggest that the cortisol awakening response does not differ between currently healthy women with and without experience of a depressive episode during late pregnancy.
  •  
70.
  • Hellgren, Charlotte, 1985-, et al. (author)
  • Cortisol awakening response in late pregnancy in women with previous or ongoing depression
  • 2013
  • In: Psychoneuroendocrinology. - 0306-4530 .- 1873-3360. ; 38:12, s. 3150-54
  • Journal article (other academic/artistic)abstract
    • Pregnancy involves an increase in basal cortisol, and a decrease in the hypothalamic-pituitary-adrenal (HPA) axis reactivity. The cortisol awakening response is a measure of HPA axis reactivity which has been reported to be altered in patients with an ongoing depressive episode, as well as in individuals with remitted depression.This study aimed to use the cortisol awakening response to study the HPA axis reactivity in relation to previous and ongoing depression in women during the third trimester of pregnancy. Based on structured interviews, and repeated questionnaires during pregnancy, 134 women were included in one of three groups: never depressed (n=57), depressed prior to the current pregnancy (n=39), and depressed during the current pregnancy (n=38). The hypothesis was that the women with ongoing, or previous, depression would have a higher cortisol awakening response than women who have never suffered from depression.Linear mixed models analysis revealed no group differences in the absolute cortisol levels or in the shape of the cortisol awakening response. We conclude that the difference in cortisol awakening response between women with and without experience of a depressive episode is not evident in late pregnancy.
  •  
Skapa referenser, mejla, bekava och länka
  • Result 61-70 of 163
Type of publication
journal article (135)
doctoral thesis (10)
research review (9)
conference paper (4)
book chapter (3)
other publication (1)
show more...
licentiate thesis (1)
show less...
Type of content
peer-reviewed (135)
other academic/artistic (28)
Author/Editor
Skalkidou, Alkistis, ... (156)
Sundström Poromaa, I ... (51)
Fransson, Emma, PhD, ... (28)
Wikström, Anna-Karin ... (16)
Hellgren, Charlotte, ... (16)
Axfors, Cathrine (15)
show more...
Iliadis, Stavros I., ... (14)
Wikman, Anna (11)
Lager, Susanne (11)
Bränn, Emma (11)
Högberg, Ulf, 1949- (10)
Comasco, Erika, 1982 ... (9)
Kullinger, Merit (9)
Kunovac Kallak, Theo ... (9)
Papadopoulos, Fotios ... (9)
Ekselius, Lisa (8)
Hesselman, Susanne, ... (8)
Sylvén, Sara, 1982- (8)
Åkerud, Helena, 1972 ... (8)
Bränn, Emma, 1988- (8)
Petridou, Eleni Th (8)
Kollia, Natasa (8)
Sylvén, Sara M., 198 ... (8)
Skoog Svanberg, Agne ... (7)
Elenis, Evangelia, 1 ... (7)
Eckerdal, Patricia, ... (7)
Papadopoulos, Fotios ... (7)
Edvinsson, Åsa, 1982 ... (7)
Georgakis, Marios K. (7)
Ramklint, Mia, Docen ... (5)
Jonsson, Maria, 1966 ... (5)
Frisell, Thomas (5)
Kallak, Theodora Kun ... (5)
Buhrman, Monica, 197 ... (5)
Kieler, Helle (5)
Skalkidou, Alkistis, ... (5)
Rubertsson, Christin ... (5)
Kimmel, Mary C. (5)
White, Richard (5)
Larsson, Anders (4)
Bergquist, Jonas (4)
Cnattingius, Sven (4)
Olivier, Jocelien (4)
Dessypris, N (4)
Henriksson, Hanna E. (4)
Munk-Olsen, Trine (4)
Cunningham, Janet (4)
Meltzer-Brody, Saman ... (4)
Cato, Karin, 1977- (4)
Hess Engström, Andre ... (4)
show less...
University
Uppsala University (163)
Karolinska Institutet (66)
Umeå University (9)
University of Gothenburg (8)
Linköping University (4)
Örebro University (3)
show more...
Mälardalen University (1)
Mid Sweden University (1)
University of Skövde (1)
Sophiahemmet University College (1)
show less...
Language
English (160)
Swedish (3)
Research subject (UKÄ/SCB)
Medical and Health Sciences (143)
Social Sciences (10)

Year

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Close

Copy and save the link in order to return to this view